1.A Critical Appraisal of COVID-19 in Malaysia and Beyond
Jafri Malin Abdullah1 ; Wan Faisham Nu&rsquo ; man Wan Ismail ; Irfan Mohamad ; Asrenee Ab Razak ; Azian Harun ; Kamarul Imran Musa ; Yeong Yeh Lee1
Malaysian Journal of Medical Sciences 2020;27(2):1-9
When the first report of COVID-19 appeared in December 2019 from Wuhan, China, the
world unknowingly perceived this as another flu-like illness. Many were surprised at the extreme
steps that China had subsequently taken to seal Wuhan from the rest of the world. However, by
February 2020, the SARS-CoV-2 virus, which causes COVID-19, had spread so quickly across the
globe that the World Health Organization officially declared COVID-19 a pandemic. COVID-19 is
not the first pandemic the world has seen, so what makes it so unique in Malaysia, is discussed to
avoid a future coronacoma.
2.Epidemiology of surgically treated patient in road traffic accident with lower extremity vascular injury from a single centre in Kelantan
Koh Siang Chai ; Wan Faisham Nu&rsquo ; man Wan Ismail ; Siti Fatimah Noor Mat Johar ; Wan Azman Wan Sulaiman ; Mohammad Paiman ; Arman Zaharil Mat Saad
The Medical Journal of Malaysia 2020;75(3):292-294
Introduction: Lower extremity vascular injury can result in
either temporary or permanent disability.
Methods: This is a clinical audit involving all patients
admitted to our institution from January 2008 to June 2018
of those who had undergone revascularization surgery for
lower limb trauma.
Results: Fifty-nine patients were in this study with a mean
age of 28.1 years. Most of the patients were motorcyclist
involved in road traffic accidents with cars (n=30, 50.8%).
The popliteal artery was most commonly seen injury (n=41,
69.5%). The mean duration of ischaemia was 14.1 hours. The
limb salvage rate was 89.8%.
Conclusion: Lower extremity vascular injury caused by RTA
treated in our institution predominantly involved young
patients aged between 18–30 years associated with long
bone fractures causing contusion and thrombosis of the
popliteal artery.
3.CASE REPORT - Delayed hypersensitivity reaction to allopurinol: A case report
Mohammad Che Man ; Shahidah Che Alhadi ; Wan Fatimah Suriyani Wan Mahmud ; Salman Amiruddin ; Mohd Zhafri Mohd Razib ; Rasimah Ismail
Malaysian Family Physician 2023;18(All Issues):1-3
Allopurinol is the well-known first-line treatment option for symptomatic hyperuricaemia and gout. It is cost-effective particularly for the management of chronic gout. The common early side effects of allopurinol are skin rashes, diarrhoea and nausea. Meanwhile, a dangerous concerning complication is Stevens–Johnson syndrome, which can cause severe morbidity and mortality. Delayed hypersensitivity to allopurinol is rare but should be one of the differential diagnoses if a patient with underlying gout on chronic allopurinol treatment presents with skin rashes. The present case highlights the importance of a high index of suspicion in at-risk patients with underlying gout along with skin rashes on long-term allopurinol treatment to avoid unnecessary patient management.
Hypersensitivity, Delayed
;
Allopurinol
;
Exanthema